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Carotid endarterectomy outcome with
vein or Dacron graft patch angioplasty
and internal carotid artery shortening
Joseph P. Archie, PhD, MD, Raleigh, NC
Objective: This analysis of the outcome of carotid endarterectomy (CEA) was performed
during a period of transition from the frequent use of autologous greater saphenous vein
grafting to the frequent use of Dacron graft patch reconstruction and from the infre-
quent use to the moderate use of eversion plication shortening of the endarterectomized
internal carotid artery segment.
Methods: From 1990 to 1997, 697 consecutive primary CEAs were performed on 326
men (61 bilateral CEAs) and 272 women (38 bilateral CEAs) with a mean age (± SD)
of 68 ± 9 years. The indications were transient ischemic attack in 31% of the patients,
stroke or reversible ischemic neurologic deficit in 18%, global ischemia in 12%, and
asymptomatic stenosis ‡ 70% in 39%. Patch reconstruction was performed in the 678
CEAs in which the arteriotomy extended distal to the internal carotid artery bulb (97%;
370 saphenous vein grafts, 308 Dacron grafts). Primary closure was used in the other
19 CEAs. Early in this series, saphenous vein patching frequently was performed, with
a gradual transition to the frequent use of knitted Dacron grafts. Concurrent with this,
the frequency of the shortening of the internal carotid artery increased from 7% to 40%.
Postoperative duplex scans were obtained on 619 CEAs (91%).
Results: There were four deaths (0.6%) in 30 days—three from myocardial infarction and
one from hyperperfusion stroke. Thirteen strokes (1.9%), nine ipsilateral and four con-
tralateral, occurred in 30 days. Four nonfatal strokes and one death occurred in the saphe-
nous vein group (3.2%), and eight strokes and two deaths occurred in the Dacron graft
group (1.4%; P = .16). The combined 30-day stroke or death rate was 2.3% (16/697), and
the hospital rate was 1.7% (12/697). Of the three internal carotid artery occlusions, two
were identified at 2 months (one Dacron graft, one saphenous vein) and one was identi-
fied at 1 year (Dacron graft). Nonocclusive (‡ 50%) restenosis was identified in 16 CEAs.
Fifteen of these were in the internal carotid artery. The cumulative Kaplan-Meier method
of life-table analysis for the ‡ 50% restenosis rate at 2 months, 6 months, 1 year, and 3 years
for Dacron graft patched CEA was 1.7%, 2.3%, 8.8%, and 12.3% and for saphenous vein
patched CEA was 0.3%, 0.3%, 0.3%, and 1.1% (P < .0001). At the same time intervals, the
‡ 50% restenosis rate for internal carotid artery shortening was 1.0%, 2.5%, 13.7%, and
19.5%, and, when shortening was not done, the rate was 0.8%, 0.8%, 1.1%, and 3.1% (P <
.0001). The ‡ 50% restenosis rate at the same intervals for women was 0.8%, 1.3%, 5.2%,
and 8.9%, and, for men, the rate was 0.9%, 0.9%, 1.8%, and 2.5% (P = .11). Univariate
analysis of the rate of ‡ 50% restenosis in 3 years for the 346 vein patched (2; 0.6%) and
186 Dacron graft patched (7; 3.8%) CEAs that did not have internal carotid artery short-
ening gave a P value of .015. Similarly, Kaplan-Meier method analysis of this subset of
nonshortened CEAs gave a higher restenosis rate with Dacron graft patching (P = .012).
With multiple logistic regression, the ‡ 50% restenosis rate was significantly associated with
Dacron graft patching (P = .023; odds ratio, 4.5) and internal carotid artery shortening
(P = .025; odds ratio, 3.1) and was weakly associated with female gender (P = .15; odds
ratio, 2.0). Cox proportional hazards model analysis for ‡ 50% restenosis gave relative risk
ratios of 3.0 (1.6 to 6.8; 95% confidence interval [CI]) for Dacron graft versus vein patch-
ing, 2.0 (1.2 to 3.3; 95% CI) for shortening versus not shortening, and 1.5 (0.9 to 2.4;
95% CI) for female versus male gender.
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Surgeons have strived to improve the outcome of
carotid endarterectomy (CEA) throughout the his-
tory of the operation. Recent prospective random-
ized studies have defined the outcome standards for
CEA to be effective in stroke prevention. The com-
bined perioperative stroke and death rate must be
less than 6% for patients who are symptomatic1 and
less than 3% for patients who are asymptomatic.2
More than two decades ago, the quest for improved
perioperative stroke and internal carotid artery
thrombosis rates and for a low incidence rate of early
and late recurrent stenosis led several surgeons to
obligatory or highly frequent selective use of the
autologous greater saphenous vein for CEA patch
reconstruction.3,4 The controversy over the advan-
tage, if any, of patching over primary closure has
recently led to six prospective randomized studies
that addressed this issue.5-10 The results of these
studies are mixed primarily because the sample sizes
were too small to achieve adequate statistical power
to detect small significant differences. However,
when the data for the three principle outcomes—
early internal carotid artery thrombosis, periopera-
tive stroke, and ‡ 50% restenosis at 1 year—are
pooled, the statistical results strongly favor patch
reconstruction.11 These six studies used several dif-
ferent types of patch materials, including autologous
greater saphenous vein, Dacron graft, polytetrafluo-
roethylene (PTFE), and autologous cervical vein.
Although patch reconstruction has become popular
in the last decade, the optimal type of patch materi-
al, if any, remains to be determined.
After I had used saphenous vein as the predomi-
nant patch material for more than a decade, I began,
in 1993, a gradual transition to the frequent use of
knitted Dacron graft patches for CEA reconstruc-
tion. The reasons for this transition were both sub-
tle and multiple. There were no data on the superi-
ority of one patch material, and both the vein grafts
and the synthetic materials had their advantages and
disadvantages. The occasional leg incision complica-
tion and patient complaints of leg wound discomfort
was one factor. Because I had had experience with
various Dacron grafts and PTFE patches as alterna-
tives when saphenous veins were not available, the
introduction in 1993 of a precut, 8-mm–wide, 
collagen-impregnated, knitted Dacron graft patch
(Meadox Medical Inc, Oakland, NJ) that was hemo-
static and easy to trim and suture was a pleasant sur-
prise. In the next year, I gradually underwent the
transition from the frequent use of greater saphe-
nous vein to the frequent use of knitted Dacron
graft. Concomitant with this transition, I noted that
Dacron graft patches more often produced tortuos-
ity or kinking distal to the cephalad end of the patch
than did saphenous vein patching. This was simply
an observation. It was not documented with quanti-
tative measurements and may not be accurate.
Accordingly, I also began to use eversion plication
shortening of the endarterectomized internal carotid
artery segment more frequently than I did vein
patched CEA. In prospective follow-up examination,
which has been my practice for two decades, it grad-
ually became apparent that the frequency of early
recurrent stenosis was probably higher after Dacron
graft patch reconstruction than after vein patch
reconstruction. This is a report of the outcome of
primary CEA performed before, during, and after
the transition from the frequent use of greater
saphenous vein patches and the occasional use of
internal carotid artery shortening to the frequent
use of knitted Dacron graft patches and the moder-
ate use of shortening.
MATERIAL AND METHODS
Patient demographics and perioperative man-
agement. From January 1990 to July 1997, 697 
consecutive primary CEAs were performed on 598
patients of whom 326 were men (61 bilateral CEAs)
and 272 were women (39 bilateral CEAs). Of the 99
bilateral procedures, in 74 both the CEAs were per-
formed within a year. The mean age (± SD) was 69 ±
9 years. The indications for CEA were transient
ischemic attack (TIA) in 217 patients (31%), reversible
ischemic neurologic deficit or minor stroke in 125
(18%), global or nonlateralizing ischemia in 84 (12%),
and asymptomatic ‡ 70% diameter stenosis in 271
(39%). The risk factors included current or previous
cigarette smoking in 502 patients (78%), hypertension
in 399 (61%), diabetes mellitus in 85 (13%), and coro-
Conclusion: CEA patching with Dacron grafts and saphenous vein grafts have similar low
perioperative thrombosis, stroke, and death rates, although the stroke and death rates
were slightly higher but not statistically different when Dacron grafts were used. Dacron
graft patched CEAs are more likely to develop ‡ 50% restenosis than are those that are
patched with saphenous vein grafts. Eversion plication shortening of the internal carotid
artery predisposes the graft to restenosis. (J Vasc Surg 1999;29:654-64.)
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nary artery disease in 446 (69%), of which 51 (8%) had
previously undergone coronary artery bypass grafting.
Coronary artery bypass grafting and CEA were per-
formed concurrently in 28 patients (4.3%), and eight
patients (1.2%) underwent coronary bypass grafting in
the first 6 months after CEA. Two patients underwent
concurrent CEA and infrarenal aortic procedures. The
distribution of indications for CEA and risk factors are
given in Table I. These were almost identical in the
subsets reconstructed with greater saphenous vein and
Dacron graft patches.
Standard or arterial digital arteriography was per-
formed on 408 patients (63%). In the other 190
patients, the degree of stenosis was determined by
means of duplex ultrasound scanning. All the
patients were monitored after surgery with electro-
cardiogram and online direct arterial pressure mea-
surements overnight. Systemic blood pressure was
maintained at 160 mm Hg or less. The patients with
ipsilateral postoperative headache were observed for
development of the hyperperfusion syndrome, and
hypertension was treated aggressively. Early in this
series, the mean postoperative hospital stay was 2.8
days. This later was shortened to 1.4 days.
Patients were followed up with office examinations
at 7 to 10 days after CEA. Routine carotid duplex
scanning was advised at 2 months, 6 months, and
annually (Ultra Mark 8 or Ultra Mark 9, Advanced
Technology Laboratories, Bothell, Wash). The criteria
for stenosis were derived from receiver operating char-
acteristic curves for our laboratory. The criteria for
50% to 69% stenosis were peak systolic velocity of
160 cm/s or more and spectral broadening. For
stenosis ‡ 70%, the criteria were peak systolic velocity
of 250 cm/s or more and end diastolic velocity of 90
cm/s or more. In addition, duplex scanning was per-
formed in the early postoperative period on patients
in whom TIA, stroke, or hyperperfusion syndrome
developed. All the data were prospectively recorded
in a computer registry.
Operative management. Standard surgical tech-
niques were used, including systemic heparin, careful
dissection before occlusion, optical magnification,
and meticulous endarterectomy and endpoint man-
agement. General anesthesia was used in all but three
CEAs, which were performed with regional block.
Intraoperative continuous wave Doppler ultrasound
scan interrogation was performed in all the CEAs
after reconstruction. A shunt was used in 83 CEAs
(11.9%) when the mean cerebral perfusion pressure
(the difference between the mean carotid stump back
pressure and the jugular venous pressure) was 18 mm
Hg or less.11 The arteriotomy that was necessary to
achieve a complete internal carotid artery endarterec-
tomy endpoint or placement of tack sutures extended
beyond the bulb segment in 678 of the CEAs (97%).
All of these patients underwent patch reconstruc-
tion.12 The other 19 CEAs (3%) in which a complete
endpoint was obtained within the bulb segment were
closed primarily. Overall, a complete internal CEA
endpoint was obtained in 677 of the CEAs (97%).
Endpoint tack sutures were used in the other 20
CEAs (2.9%) when the tongue of plaque extended
distally and could not be completely removed.
Between 1990 and 1993, autologous greater saphe-
nous vein was used as a patch 95% of the time and
Dacron graft was used the other 5%. During the tran-
sition year from 1993 to 1994, the distribution of
patch material was approximately 50% Dacron graft
and 50% vein graft. From 1994 to mid 1997, 91% of
the patched CEAs were performed with knitted
Dacron grafts and the remainder were performed
with vein grafts.
Although the technique of saphenous vein patch
Table I. Distribution of indications and systemic risk factors by reconstruction type
Vein patch (%) Dacron graft patch (%) Primary closure (%) Total (%)
Indications
TIA 123 (33) 86 (29) 6 (32) 215 (31)
RIND/stroke 63 (17) 58 (19) 4 (21) 125 (18)
Global 46 (12) 36 (12) 2 (10) 84 (12)
Asymptomatic 138 (37) 128 (41) 7 (37) 273 (39)
TOTAL 379 (100) 308 (100) 19 (100) 697 (100)
Systemic risk factors
Male gender 209 (57) 169 (55) 9 (47) 387 (56)
Coronary artery disease 261 (70) 207 (67) 11 (59) 479 (69)
Diabetes mellitus 46 (12) 41 (13) 3 (16) 90 (13)
Hypertension 231 (62) 186 (60) 11 (58) 428 (61)
Smoking 291 (78) 236 (77) 14 (74) 541 (78)
TIA, Transient ischemic attack; RIND, reversible ischemic neurologic deficit.
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reconstruction differs somewhat from that of Dacron
graft patch use, the resulting geometry is almost
identical.13 Dacron graft patches necessitate accurate
trimming to give a smoothly tapered transition in
diameter from the carotid bifurcation to the uniform
diameter of the distal internal carotid artery. In con-
trast, because of its elasticity, saphenous vein neces-
sitates accurate suture placement rather than trim-
ming and shaping to achieve the same goal.
Although veins with distended diameters of 6 mm or
more are best trimmed, the excess is more easily
incorporated into the suture line rather than the vein
being shaped before suturing. Before the frequent
use of Dacron graft as a patch material, approxi-
mately 7% of the CEAs with saphenous vein patch
reconstruction also had eversion plication shorten-
ing of redundant endarterectomized internal carotid
arteries to prevent kinking at or distal to the cepha-
lad end of the patch.12 After more experience with
Dacron grafts, it was noted that, when patched, even
mildly redundant endarterectomized segments of
internal carotid artery tended to produce distal tor-
tuosity or mild or moderate kinks. Accordingly, the
frequency of the shortening of the internal carotid
artery increased to 40% of the Dacron graft patched
CEAs. The technique used has been reported12 and
is similar to that described to me by Dr Thomas
Riles in 1987. The proximal, 1-cm to 2-cm segment
of internal carotid artery is removed from the flow
surface by everting it with a running 6-0 polyethyl-
ene suture circumferentially before reconstruction.
Overall, 122 of 308 Dacron graft patched CEAs
(40%), 24 of 370 vein patched CEAs (6.6%), and 1
of 19 primarily closed CEAs (5.3%) had internal
carotid artery shortening.
Computer registry and statistical analysis. All
the patient demographics, operative measurements,
and perioperative outcome data were prospectively
entered into a registry on a weekly or biweekly basis.
The follow-up duplex scan data were compiled and
entered annually or semiannually. Statistical analyses
were performed with JMP, version 3.1 (SAS Institute,
Cary, NC). Analysis included unpaired t testing, two-
tailed Fisher exact test, c 2 test, analysis of variance,
multiple logistic regression, Kaplan-Meier method of
life-table analysis, and Cox proportional hazards
model analysis. The statistical power was calculated
with continuity correction for a = 0.05.
RESULTS
Perioperative morbidity and mortality rates.
The 30-day hospital and posthospital rates and the
30-day death and stroke rates are given in Table II.
The combined 30-day stroke and death rate was
Fig 1. Life-table analysis of ‡ 50% restenosis free carotid endarterectomy with Dacron graft
and greater saphenous vein patch reconstruction (P < .001, with log-rank test and Wilcoxon
rank sum test).
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2.3%, and the hospital rate was 1.7%. Of the four
deaths, three were caused by acute myocardial
infarction and one was caused by the hyperperfusion
syndrome. Of the 13 strokes, nine were ipsilateral to
the CEA, three were contralateral, and one was pos-
terior. One contralateral stroke occurred in a patient
who underwent a combined CEA and coronary
bypass grafting procedure. Six of the nine ipsilateral
strokes occurred during the operations. Before
surgery, seven patients had frequent recurrent or
crescendo TIAs and two others had unstable mild
neurologic deficits. Of these nine patients, two had
an operative stroke (P = .03; power = 0.75). 
One ipsilateral operative stroke was caused by an
embolus from the endarterectomy-produced com-
mon carotid step, one was from emboli produced
from the common carotid end of a shunt, one was
from retained disease in the external carotid artery,
and the sixth was presumed to be caused by emboli
of unknown cause. Immediate postoperative duplex
scanning results were normal in all five patients with
ipsilateral operative strokes. The other patient had a
flap at a 2-mm common carotid step. Two of the
three early postoperative ipsilateral strokes were pre-
sumed to be caused by emboli, and the other one
was caused by the hyperperfusion syndrome. All
three patients had normal postoperative duplex scan
results. As given in Table I, the combined 30-day
stroke or death rate for vein patched CEA was 1.4%
(5 of 370) and for Dacron graft patched CEA was
3.2% (10 of 306; P = .16, power = 0.30). There was
a 70% chance that this was a false negative or a type
II error. All three unexplained ipsilateral strokes
(one operative, two postoperative) occurred in
Dacron graft patched CEAs (P = .12, power = 0.28)
when compared with vein patched CEAs. Taken sep-
arately, there was no significant difference in the
death or stroke rates between the patch materials,
patient gender, indications for CEA, risk factors, and
the use of shortening.
Seven patients had TIAs in the postoperative
period. Three of the TIAs were identical to preoper-
ative symptoms and were cleared. One patient with
multiple TIAs, which were cleared with anticoagula-
tion therapy, was found to have a flap at the com-
mon carotid step on duplex scan. The causes of the
TIAs in the other three patients were not identified.
All the TIAs were resolved, and the duplex scan
results were normal.
Other morbidity included myocardial infarction
in three patients, two of whom underwent coronary
artery bypass grafting. Intractable angina developed
in two patients within 2 weeks of CEA. These
patients underwent coronary bypass grafting. One
patient had a 2 cm–diameter false aneurysm in the
suture line of a vein patch discovered at 2 months
after CEA that was repaired with a single stitch. Two
patients had recurrent laryngeal nerve paralysis, and
one condition resolved in 3 months. There were no
patch ruptures or cervical wound infections. Two
patients had minor wound infections after vein har-
vest from the upper thigh.
Restenosis. The 36-month life-table analyses
for ‡ 50% restenosis free intervals for Dacron graft
and vein patched CEAs are given in Fig 1 and Table
II. The mean follow-up period for Dacron graft
patched CEA was 23 months and for vein patched
CEA was 59 months. The difference in restenosis
Table II. Perioperative death and stroke rates
Death Stroke Stroke or death
No. No. % ± 95% CI No. % ± 95% CI No. % ± 95% CI
All at 30 days 697 4 0.6 0.6 13 1.9 1.0 16 2.3 1.1
Hospital 697 2 0.3 0.4 10 1.4 0.9 12 1.7 1.0
After hospital at 30 days 695 2 0.3 0.4 3 0.4 0.5 4 0.6 0.6
Gender at 30 days
Male 387 2 0.5 0.7 9 2.3 1.5 10 2.6 1.6
Female 310 2 0.6 0.9 4 1.3 1.2 6 1.9 1.5
Reconstruction type at 30 days
Primary closure 19 1 5.3 10.0 0 0 0 1 5.2 10.0
Vein patch 370 1 0.3 0.5 5 1.4 1.2 5 1.4 1.2
Dacron graft patch 307 2 0.7 0.9 8 2.6 1.8 10 3.2 1.1
All patch 677 3 0.4 0.5 13 1.9 1.0 15 2.2 1.1
Shortening at 30 days
Yes 147 0 0 0 1 0.7 1.3 1 0.7 1.3
No 550 4 0.7 0.7 12 2.2 1.2 15 2.7 1.4
CI, Confidence interval.
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rate is significant with log-rank test (P < .0001) and
Wilcoxon rank sum test (P < .0001) analysis. Of the
19 CEAs with primary closure, 16 patients had post-
CEA duplex scans with a mean follow-up period of
27 months without ‡ 50% restenosis. The 36-month
life-table analysis for ‡ 50% restenosis free intervals
for CEA with and without internal carotid artery
shortening is given in Fig 2 and Table II. The dif-
ference in restenosis rate is significant with log-rank
test (P < .0001) and Wilcoxon rank sum test (P <
.0001) analysis. Fig 3 and Table II show the 3-year
life-table analysis for male and female CEAs.
Although the incidence rate of restenosis was higher
in women than in men, the difference was not sig-
nificant (P = .06 with log-rank test, and P = .11 with
Wilcoxon rank sum test analysis).
Fig 2. Life-table analysis of ‡ 50% restenosis free carotid endarterectomy with and without
eversion plication shortening of endarterectomized internal carotid artery segment (P < .001,
with log-rank test and Wilcoxon rank sum test).
Table III. Life-table analysis for freedom from ‡ 50% restenosis free periods for Dacron graft and vein graft
patched carotid endarterectomies
Interval No. at risk No. failed No. censored Cum freedom Standard error
Dacron graft
0 263 1 30 0.996 0.004
2 232 3 66 0.983 0.008
6 163 1 32 0.977 0.010
12 130 8 55 0.917 0.023
24 67 3 39 0.876 0.032
36 25 0 20 0.876 0.032
Vein graft
0 335 1 16 0.997 0.003
2 318 0 32 0.997 0.003
6 286 0 43 0.997 0.003
12 243 0 77 0.997 0.003
24 166 0 67 0.997 0.003
36 99 1 45 0.987 0.010
P < .001, with log-rank test and Wilcoxon rank sum test.
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Overall, of the 19 ‡ 50% restenosis or internal
carotid artery occlusions, 16 occurred in the 308
Dacron graft patched CEAs and three in the 370 vein
patched CEAs (P = .001). Internal carotid artery
shortening was performed in 147 CEAs, of which 10
had restenosis or occlusion. Only nine of the other
550 CEAs had restenosis or occlusion (P = .001).
There were seven restenoses or occlusions in the 387
CEAs performed on men and 12 in the 310 CEAs
performed on women (P = .15, power = 0.39).
Screening multiple logistic regression for patch
material, shortening, gender, continued or current
smoking, coronary artery disease, diabetes mellitus,
and hypertension revealed that only the first three
were correlated with ‡ 50% restenosis. Repeat analysis
with these three independent variables identified ‡ 50%
Table IV. Life-table analysis for freedom from ‡ 50% restenosis free periods for internal carotid artery pli-
cation with and without shortening
Interval No. at risk No. failed No. censored Cum freedom Standard error
With shortening
0 110 1 15 0.991 0.009
2 94 0 30 0.991 0.009
6 64 1 11 0.975 0.018
12 52 6 31 0.863 0.046
24 15 1 11 0.805 0.070
36 3 0 2 0.805 0.070
Without shortening
0 502 1 33 0.998 0.002
2 468 3 74 0.992 0.004
6 391 0 64 0.992 0.004
12 327 2 104 0.986 0.006
24 221 2 96 0.977 0.009
36 123 1 63 0.969 0.012
P < .001, with log-rank test and Wilcoxon rank sum test.
Fig 3. Life-table analysis of ‡ 50% restenosis free carotid endarterectomy in men and women
(P = .056, with log-rank test; P = .109, with Wilcoxon rank sum test).
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restenosis to be associated with Dacron graft patch
material (P = .023; odds ratio, 4.5; 95% confidence
interval [CI], 1.4 to 20.5), internal carotid artery
shortening (P = .025; odds ratio, 3.1; 95% CI, 1.2 to
8.4), and female gender (P = .15; odds ratio, 2.0; 95%
CI, 0.8 to 5.5). Cox proportional hazards model
analysis is a more accurate method of multivariant test-
ing for relationships between dependent variables
when the independent or effect variable occurs over
time, in this case ‡ 50% restenosis. Cox proportional
hazard analysis for these three variables gives results
similar to multivariant analysis. The ‡ 50% restenosis
risk ratio for Dacron graft versus vein graft is 3.0 (95%
CI, 1.6 to 6.8), for shortening versus not shortening
2.0 (95% CI, 1.2 to 3.3), and for female versus male
gender 1.5 (95% CI, 0.9 to 2.4). The effect likelihood-
ratio probability for Dacron graft versus vein graft was
0.0005, for shortening versus no shortening was
0.007, and for female versus male was 0.10.
To further evaluate the restenosis relationship
between patch materials and shortening, univariate
analysis of the 3-year rate of ‡ 50% restenosis was
performed and is shown in Table VI for the subsets
with and without internal carotid artery plication
shortening. Although nonshortened Dacron graft
patched CEAs have higher restenosis rates than do
vein patched CEAs (P = .015), the shortened ones
did not achieve statistical significance. This may be a
result of a type II statistical error because of the
small number of vein patched CEAs that were short-
ened. Further, Kaplan-Meier method of life-table
analysis of both the shortened and the nonshortened
vein graft versus Dacron graft patched subsets gave
curves similar to those shown in Fig 1. The cumula-
tive freedom from ‡ 50% restenosis for nonshortened
CEAs at 1, 2, and 3 years was 0.93, 0.89, and 0.89
for Dacron grafts and 0.99, 0.99, and 0.98 for vein
grafts (P = .012 with log-rank test; P = .021 with
Wilcoxon rank sum test). For the shortened subsets,
the cumulative freedom from ‡ 50% restenosis at 1,
2, and 3 years was 0.88, 0.86, and 0.86 for Dacron
grafts and 1.0, 1.0, and 1.0 for vein grafts (P = .007
with log-rank test; P = .013 with Wilcoxon rank sum
test). These results support the conclusion that
Dacron graft patched CEAs have a significantly
higher incidence rate of restenosis than do vein
patched CEAs independent of shortening.
Characteristics and location of restenosis.
There were three asymptomatic internal carotid
artery occlusions identified with duplex scanning.
Two of these were found 2 months after CEA—one
with a Dacron graft and one with a vein patch. This
was the first early postoperative occlusion identified
in approximately 950 consecutive vein patched pri-
mary CEAs. This male patient, a heavy smoker, was
seen 10 days after CEA with deep venous thrombo-
sis in the leg from which the greater saphenous vein
patch had been harvested above the ankle. He
underwent treatment with heparin and warfarin and
has had no residual leg sequela at 2 years. The third
asymptomatic internal carotid artery occlusion iden-
tified at 6 months after CEA was in a woman with
Dacron graft patch reconstruction who had normal
duplex scan results at 2 months.
Of the 16 nonocclusive ‡ 50% restenoses identi-
fied, 15 were in the internal carotid artery segment.
Two of these were at the distal end of the patch. Both
patients underwent Dacron graft patch reconstruc-
tion. These were the only two of the 20 CEAs (10%)
with endpoint tack sutures found to have significant
Table V. Life-table analysis for freedom from ‡ 50% restenosis free periods for gender
Interval No. at risk No. failed No. censored Cum freedom Standard error
Female gender
0 267 0 25 1.00 0.00
2 242 2 43 0.992 0.006
6 197 1 43 0.987 0.008
12 152 6 52 0.948 0.017
24 95 2 39 0.928 0.022
36 54 1 25 0.911 0.027
Male gender
0 345 2 23 0.994 0.004
2 320 1 61 0.991 0.005
6 258 0 32 0.991 0.005
12 226 2 83 0.982 0.008
24 141 1 68 0.975 0.010
36 72 0 40 0.975 0.010
P = .056, with log-rank test.
P = .109, with Wilcoxon rank sum test.
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residual or restenosis (P = .05, power = 0.66). The
other restenosis occurred in the common carotid
artery of a woman 6 years after the vein patch recon-
struction. This was an 80%+ concentric stenosis at the
level of a 2-mm-deep endarterectomy-produced com-
mon carotid step. There was minimal stenosis noted at
this location 4 years after CEA. Of the 16 nonocclu-
sive ‡ 50% restenoses, seven were ‡ 70%. Of these
seven, six were patched with Dacron graft and one
with vein graft (P = .05, power = 0.51). Three of these
patients underwent reoperation—the 80%+ common
carotid step stenosis at 6 years, and two symptomatic
Dacron graft patched CEAs at 9 and 20 months.
The intraoperative post-CEA reconstruction
geometry was routinely measured as previously
reported.13 The major difference in geometry
between shortened and nonshortened CEA was the
length of the internal carotid artery bulb or patch seg-
ment, 16.2 ± 5.2 mm and 21.6 ± 5.8 mm, respec-
tively (P <.001). There was a 4% or less difference in
the mean values of the carotid diameters and the angle
of incidence of tapering of the internal carotid artery
for Dacron graft and vein patched CEAs. There was
no difference in the geometry of carotid arteries that
restenosed compared with those that did not for both
the shortened and nonshortened groups.
DISCUSSION
There are two statistically and clinically significant
findings in this analysis. First, recurrent ‡ 50% steno-
sis is more likely to occur in CEAs reconstructed with
Dacron graft patches than in those with autologous
greater saphenous vein patches. Second, eversion pli-
cation shortening of the endarterectomized internal
carotid artery segment predisposes to restenosis. In
addition, the incidence rate of 30-day stroke or death
was higher (3.2%) in Dacron graft patched CEAs
than in those patched with saphenous vein (1.4%; P
= .16). These data suggest that strong consideration
be given to the use of greater saphenous vein over
knitted Dacron graft when patch reconstruction is
performed. Liberal use of plication shortening is not
advisable. Shortening should be limited to the 5% to
10% of CEAs with clear redundant endarterec-
tomized internal carotid artery segments.
There are six studies that include a mix of greater
saphenous vein and either Dacron graft or PTFE
patched CEAs.6,10,14-17 However, there are no prior
reports on the association of plication shortening on
outcome. The perioperative stroke rate for Dacron
graft and vein patched CEAs in five of these studies is
variable and inconclusive. The sixth study from the
Cleveland Clinic15 indicates that the hospital stroke
rate with saphenous vein patched CEAs is significant-
ly lower than that of synthetic patched CEAs (P =
.028; odds ratio, 2.6; 95% CI, 1.2 to 5.3). If the peri-
operative stroke rates from these six studies6,10,14-17
are pooled (meta-analysis), the incidence rate is 2.7%
for 2225 synthetic patches and 1.2% for 1426 saphe-
nous vein patches (P = .002, power = 0.88 for a =
0.05).18 Three studies have perioperative stroke 
data for Dacron graft and saphenous vein patched
CEAs.14,16,17 The pooled 598 CEAs with Dacron
graft patches had a 3.0% stroke rate, and the 675
CEAs with vein patches had a 1.0% rate (P = .025,
power = 0.68 for a = 0.05).18 These pooled results are
similar to the 2.6% and 1.4% perioperative stroke rates
reported herein for Dacron graft and vein graft,
respectively. Given the many causes of perioperative
stroke, these data indicate that patch material may be
a major determinant of perioperative stroke and that
autologous greater saphenous vein is superior to syn-
thetic patches in general and to Dacron graft in par-
ticular. Three of these studies10,14,17 have data on
‡ 50% restenosis in the first year after CEA. The
pooled 725 CEAs with synthetic patches had a 3.0%
incidence rate of restenosis, and the 479 vein patched
CEAs had a 1.2% rate (P = .07). These results are sim-
ilar to the cumulative ‡ 50% stenosis rate at 6 months
for Dacron graft patched CEAs (2.3%) and for vein
Table VI. Univariant analysis of the incidence rate of ‡ 50% stenosis in 3 years after carotid endarterectomy
with and without internal carotid artery plication shortening
Not Shortened Shortened P value
Shortened vs 
Patch type No. CEA No. ‡ 50% stenosis No. CEA No. ‡ 50% stenosis not shortened
Vein graft 346 2 (0.6%) 24 0 (0%) 0.8 (F)
Dacron graft 186 7 (3.8%) 122 9 (7.4%) 0.26 (c 2)
P value for vein graft vs Dacron graft .015 (F) .27 (F)
Vein graft and Dacron graft 532 9 (1.7%) 146 9 (6.2%) 0.007 (c 2)
CEA, Carotid endarterectomy.
P values are with two-tailed Fisher exact test (F) and c 2 test (c 2).
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 4 Archie 663
patched CEAs (0.3%) reported herein. However, at 1
year, the rate of ‡ 50% restenosis reported herein for
Dacron graft was 8.3%. One of the studies that com-
pared saphenous vein with Dacron graft patched CEA
had a 66% incidence rate of eversion plication short-
ening of the internal carotid artery, but the authors
did not report an analysis of the effect of shortening,
if any, on restenosis.17
Although the popularity of CEA patch recon-
struction continues to increase, some surgeons cor-
rectly challenge the advantage of patching on out-
come.19 The best analysis of the current status of the
question of patching versus primary closure is
obtained with a meta-analysis of the six published
prospective randomized trials.5-10 This analysis of
pooled data on 462 primary closure CEAs, 242
saphenous vein patched CEAs, and 399 synthetic
(Dacron graft and PTFE) patched CEAs for early
postoperative internal carotid artery thrombosis gives
a 4.3% rate for primary closure, 0.4% for vein graft,
1.0% for synthetic grafts, and 0.8% for all patched
CEAs (P = .004, power = 0.97 for primary closure vs
vein; P = .006, power = 0.98 for primary closure vs
synthetic; and P = .001, power = 0.99 for primary clo-
sure vs all patches).18,20 Perioperative stroke occurred
in 3.9% of the primary closures, 1.2% of the saphe-
nous veins, 1.2% of the synthetic grafts, and 1.2% of
all the patches (P = .08 for primary closure vs vein; P
= .03 for primary closure vs synthetics; and P = .008,
power = 0.03 for primary closure vs all patched
CEAs).18,20 In addition, the incidence rate of periop-
erative stroke in six nonrandomized studies that con-
tained both primary closure and patch reconstruction
is positively and linearly related to the percentage of
patients who underwent primary closure.18 The high-
er the percentage of CEA reconstructed with primary
closure the higher the rate of perioperative stroke
ranging linearly from 1% for obligatory patching to
3.5% for obligatory primary closure.18
Data on ‡ 50% stenosis in the first year after CEA
from these six studies5-10 were available on 448 pri-
mary closures, 223 vein grafts, 368 synthetic grafts,
and 591 total patched CEAs. The restenosis rate was
7.4% for primary closure, 2.3% for vein patch, 1.9%
for synthetic patch, and 2.1% for all patched CEAs (P
= .02 for primary closure vs vein graft; P = .003 for
primary closure vs synthetic graft; and P < .001,
power = 0.99 for primary closure vs all patched
CEAs).18,20 If these pooled data are representative of
the thrombosis, stroke, and early residual/restenosis
rates for the population undergoing CEA, highly fre-
quent or obligatory patch reconstruction is strongly
advisable. If this is true, the major unanswered ques-
tion is the optimal patch material. As discussed
above, there are data that support the use of autolo-
gous greater saphenous vein as a patch over synthet-
ics in general and Dacron graft in particular.
Given the current availability of precut knitted
Dacron graft and PTFE patches that are relatively
inexpensive and easy to trim and suture, it may be
difficult to persuade surgeons to harvest a saphenous
vein. However, if one takes into consideration that
the best possible combined 30-day stroke and death
rate for CEA is 1%,18 a reduction of stroke rate by
1% to 2% by vein patching over synthetics may be
extremely valuable. Although ‡ 50% restenosis may
not be as serious a consideration as perioperative
stroke, restenosis can lead to symptoms or occlusion
and may necessitate reoperation. The results report-
ed herein strongly suggest an advantage of saphe-
nous vein over Dacron graft patching in this regard.
During the period of this study, 23 patients
underwent staged bilateral CEA within 2 months
with a Dacron graft patch on one side and a greater
saphenous vein patch on the other. Most of these
cases occurred during the transition period from
1993 to 1994. In 1-year and 2-year follow-up exam-
inations, the ultrasound scan–measured common
carotid bulb wall thickness was highly variable
between patients but was almost identical within
patients.21 This finding led me to believe that both
types of patch materials, vein graft and Dacron graft,
would probably have similar recurrent stenosis rates.
I therefore was surprised to subsequently observe an
increasing number of patients with Dacron graft
patches who were seen in follow-up examination
with recurrent stenosis. The wall thickness in the
common carotid artery after CEA may not be an
indicator or predictor of restenosis in the internal
carotid artery segment. These observations prompt-
ed the analysis reported herein.
The high rate of restenosis in CEA undergoing
eversion plication shortening of redundant segments
of endarterectomized internal carotid arteries is
troubling. The reason for this is unclear. Shortening
significantly decreases the length of the internal
carotid artery patched segment, but the other geo-
metric dimensions, internal carotid artery bulb
diameter, and taper angle are only minimally affect-
ed by shortening. The technique of a running cir-
cumferential suture in the first segment of the inter-
nal carotid artery could be a nidus for restenosis. In
discussing this technique recently with Dr Thomas
Riles, who first showed me the technique, he rec-
ommended eversion shortening more distally in the
internal carotid artery endarterectomized segment,
which is his practice.17 This difference in technique
may be significant in terms of recurrent stenosis. Of
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the 10 of 147 CEAs (7%) with restenosis or occlu-
sion after shortening, all restenosis occurred in the
proximal or midinternal carotid artery. These find-
ings make the technique or the suture location line
suspect. Failure to use shortening in some CEAs
leads to kinking at or distal to the apex of a patch.
Other technical problems, such as the failure to
properly tailor and taper the distal end of a patch
reconstruction or the use of a patch that is too short
to allow for the medial curvature or to accommo-
date the arteriotomy length, may result in an ellipti-
cal cross section and kinking at the apex. However,
even a properly placed patch in a redundant artery
that produces kinking and shortening is advisable.
Although the outcomes reported herein were
recorded prospectively, this is not a prospective or a
randomized study of either patch material or plica-
tion shortening. This type of study needs to be done.
However, the technique of CEA was otherwise iden-
tical throughout this time period. All the procedures
were performed by the author who had a prior expe-
rience with more than 1000 CEAs. Although it is not
advisable to change two variables, patch material and
incidence of shortening in this series, in the same
time period, appropriate statistical analyses are avail-
able. Cox proportional hazards model, multiple
logistic regression, univariate c 2 test, and Fisher exact
test were applied. These tests all indicate that Dacron
graft patching as compared with vein patching and
internal carotid artery shortening is an independent
risk factor for restenosis. The finding of a slightly but
not statistically significant higher restenosis rate in
women when compared with men is not new and is
generally known. The finding of a higher restenosis
rate after Dacron graft patching when compared with
vein patching is of importance and may serve as a
motivation for a prospective randomized study, such
as the one currently underway at the Cleveland
Clinic.15 The observation of a higher restenosis rate
in CEAs with plication shortening is new and must
be investigated further.
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